- Synonyms(E)-N-(4-((3-chloro-4-fluorophenyl)(4-((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
- Description
(E)-N-(4-((3-chloro-4-fluorophenyl)(4-((4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-1-(dimethylamino)-4-oxobutan-2-yl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
Afatinib -4-(dimethylamino)butanoic acid dimer impurity is a fully characterized chemical compound used as a reference standard of API Afatinib. The standard offered is compliant with regulatory guidelines. Afatinib -4-(dimethylamino)butanoic acid dimer impurity is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -
Related products
4-(3-Chloro-4-fluorophenylamino)-7-fluoro-6-nitroquinazoline

M.F.
M.W. 336.69
CAT# AR-A01482
CAS# 162012-67-1